UBS Group’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.3K Buy
122,201
+13,796
+13% +$4.1K ﹤0.01% 6729
2025
Q1
$33.1K Buy
108,405
+74,871
+223% +$22.8K ﹤0.01% 6584
2024
Q4
$96.4K Buy
33,534
+33,463
+47,131% +$96.2K ﹤0.01% 5681
2024
Q3
$183 Sell
71
-381
-84% -$982 ﹤0.01% 7869
2024
Q2
$886 Buy
+452
New +$886 ﹤0.01% 7583
2024
Q1
Sell
-814
Closed -$3.38K 8424
2023
Q4
$3.38K Sell
814
-334
-29% -$1.39K ﹤0.01% 6772
2023
Q3
$1.58K Sell
1,148
-124
-10% -$171 ﹤0.01% 6741
2023
Q2
$3.98K Sell
1,272
-34
-3% -$106 ﹤0.01% 6500
2023
Q1
$4.44K Buy
1,306
+306
+31% +$1.04K ﹤0.01% 7091
2022
Q4
$4.5K Buy
+1,000
New +$4.5K ﹤0.01% 8128
2022
Q3
Sell
-64
Closed -$1K 9481
2022
Q2
$1K Sell
64
-1,429
-96% -$22.3K ﹤0.01% 8854
2022
Q1
$26K Buy
1,493
+504
+51% +$8.78K ﹤0.01% 6110
2021
Q4
$32K Sell
989
-363
-27% -$11.7K ﹤0.01% 6223
2021
Q3
$54K Buy
1,352
+652
+93% +$26K ﹤0.01% 5184
2021
Q2
$11K Hold
700
﹤0.01% 6866
2021
Q1
$13K Buy
700
+247
+55% +$4.59K ﹤0.01% 6713
2020
Q4
$11K Buy
453
+253
+127% +$6.14K ﹤0.01% 6387
2020
Q3
$4K Buy
+200
New +$4K ﹤0.01% 6532
2019
Q4
Sell
-282
Closed -$3K 7118
2019
Q3
$3K Buy
+282
New +$3K ﹤0.01% 6671
2019
Q2
Sell
-157
Closed -$3K 7060
2019
Q1
$3K Buy
+157
New +$3K ﹤0.01% 6501
2018
Q4
Sell
-175
Closed -$14K 7149
2018
Q3
$14K Buy
175
+44
+34% +$3.52K ﹤0.01% 6082
2018
Q2
$12K Sell
131
-61
-32% -$5.59K ﹤0.01% 6114
2018
Q1
$16K Sell
192
-29
-13% -$2.42K ﹤0.01% 5687
2017
Q4
$14K Buy
221
+102
+86% +$6.46K ﹤0.01% 5836
2017
Q3
$7K Buy
+119
New +$7K ﹤0.01% 6153